Arizona PSPRS Trust Takes $895,000 Position in agilon health, inc. (NYSE:AGL)

Arizona PSPRS Trust purchased a new stake in shares of agilon health, inc. (NYSE:AGL) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 227,800 shares of the company’s stock, valued at approximately $895,000. Arizona PSPRS Trust owned 0.06% of agilon health as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Citigroup Inc. grew its holdings in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares during the period. AQR Capital Management LLC increased its holdings in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in agilon health by 18.7% in the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after buying an additional 174,883 shares during the period. Susquehanna Fundamental Investments LLC grew its position in shares of agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after buying an additional 316,856 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of agilon health by 6.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 640,048 shares of the company’s stock valued at $2,515,000 after acquiring an additional 37,725 shares during the period.

Insiders Place Their Bets

In other news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This represents a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 3.20% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AGL shares. Royal Bank of Canada restated an “outperform” rating and set a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. TD Cowen reduced their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Evercore ISI reduced their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Finally, Benchmark reiterated a “buy” rating and set a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $6.05.

agilon health Stock Down 0.9 %

agilon health stock opened at $2.09 on Monday. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $13.76. The stock has a market cap of $861.12 million, a P/E ratio of -2.22 and a beta of 0.60. The company’s 50-day moving average price is $2.73 and its two-hundred day moving average price is $4.63. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the company earned ($0.06) earnings per share. As a group, analysts expect that agilon health, inc. will post -0.47 EPS for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.